Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Anemia and TYMS[original query] |
---|
Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902. Cancer chemotherapy and pharmacology 2014 Dec 74 (6): 1149-57. Kanazawa Kenya, Yokouchi Hiroshi, Wang Xintao, Ishida Takashi, Fujita Yuka, Fujiuchi Satoru, Harada Toshiyuki, Harada Masao, Takamura Kei, Oizumi Satoshi, Kinoshita Ichiro, Katsuura Yutaka, Honjo Osamu, Kojima Tetsuya, Dosaka-Akita Hirotoshi, Isobe Hiroshi, Munakata Mitsuru, Nishimura Masaharu, |
Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2018 Feb 9 (10): 9114-9136. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Butkiewicz Dorota, Grzybowska E |
The Role of Dihydropyrimidine Dehydrogenase and Thymidylate Synthase Polymorphisms in Fluoropyrimidine-Based Cancer Chemotherapy in an Iranian Population. Avicenna journal of medical biotechnology 0 12 (3): 157-164. Abbasian Mohammad Hadi, Ansarinejad Nafiseh, Abbasi Bahareh, Iravani Masoud, Ramim Tayeb, Hamedi Fahime, Ardekani Ali |
Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer. Cancer chemotherapy and pharmacology 2023 10 . Yao Liang, Osamu Maeda, Kazushi Miyata, Mitsuro Kanda, Shizuki Sugita, Dai Shimizu, Kazuki Nishida, Yasuhiro Kodera, Yuichi An |
- Page last reviewed:Feb 1, 2024
- Content source: